Gsa Capital Partners LLP Obs Eva Sa Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.99 - $3.1 $63,751 - $99,311	-32,036 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.47 - $3.34 $79,128 - $107,000	32,036 New	32,036 $100,000
Q1 2021 May 10, 2021	SELL	$2.01 - $5.05 $100,946 - $253,621	-50,222 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$1.89 - $2.55 $66,068 - $89,140	34,957 Added 229.0%	50,222 $104,000
Q3 2020 Nov 06, 2020	BUY	$2.46 - $6.15 $37,551 - $93,879	15,265 New	15,265 $38,000
Q4 2018 Feb 12, 2019	SELL	$10.8 - $17.94 $431,082 - $716,075	-39,915 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.92 - $18.18 $435,871 - $725,654	39,915 New	39,915 $720,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.